Ad
related to: respiratory pharmacology quiz
Search results
Results From The WOW.Com Content Network
The following is a list of key pharmaceuticals in the prevention and treatment of respiratory-related ailments. Adrenergic (Sympathomimetic) Bronchodilators [ edit ]
In pharmacology and toxicology, a route of administration is the way by which a drug, fluid, poison, or other substance is taken into the body. [1] Routes of administration are generally classified by the location at which the substance is applied. Common examples include oral and intravenous administration. Routes can also be classified based ...
Hyoscine butylbromide reduces smooth muscle contraction and the production of respiratory secretions. These are normally stimulated by the parasympathetic nervous system, via the neurotransmitter acetylcholine. As an antimuscarinic, hyoscine butylbromide binds to muscarinic acetylcholine receptors, blocking their effect. [25]
Candidate must be 18 years old and must have either: a minimum of an associate degree from a respiratory therapist education program accredited by the Commission on Accreditation for Respiratory Care (CoARC), or hold the Canadian Society of Respiratory Therapists (CSRT) RRT credential. The TMC consists of 160 multiple-choice questions (140 ...
Salicylate poisoning, also known as aspirin poisoning, is the acute or chronic poisoning with a salicylate such as aspirin. [1] The classic symptoms are ringing in the ears, nausea, abdominal pain, and a fast breathing rate. [1]
In the fields of medicine, biotechnology, and pharmacology, drug discovery is the process by which new drugs are discovered. [citation needed] Historically, drugs were discovered by identifying the active ingredient from traditional remedies or by serendipitous discovery.
Nirsevimab, sold under the brand name Beyfortus, is a human recombinant monoclonal antibody with activity against respiratory syncytial virus (RSV). [10] [11] It is a respiratory syncytial virus (RSV) F protein‑directed fusion inhibitor [6] that is designed to bind to the fusion protein on the surface of the RSV virus.
Pulmonary Pharmacology & Therapeutics is a medical journal published by Elsevier that covers research on the pharmacotherapy of lung diseases. It was established in 1988 as Pulmonary Pharmacology and obtained its current title in 1997.